"Guys I really can't express my joy with this study result!
For context - Renalytix's KidneyIntelX was USD$635M over a 5 year term.
PromarkerD $862M over 4 years significantly trumps KidneyIntelX"
Aren't your figures significantly out?
The KidneyIntelx figure of $635M US is a total saving
The PIQ figure of $862M US is a saving - per million patients
So the financial advantage is significantly better once extrapolated over a factor of many millions of users
Ann: Major economic health benefit demonstrated for PromarkerD, page-10
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $62.19M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10180 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 796 | 1 |
View Market Depth
| Last trade - 10.00am 08/08/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |
Day chart unavailable